Professional
Added to YB: 2025-10-09
Pitch date: 2025-08-29
ICCC [neutral]
ImmuCell Corporation
-1.27%
current return
Author Info
No bio for this author
Company Info
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.
Market Cap
$54.7M
Pitch Price
$6.29
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.84
P/E
23.43
EV/Sales
2.32
Sector
Biotechnology
Category
value
SRK Capital Portfolio Holding: ImmuCell Corporation
ICCC (holding update): Record Q1 results w/ 42% gross margins expanding to 45% target. Production stabilized after contamination issues, enabling new bulk powder First Defense expansion into large ranch market. Re-Tain FDA approval delayed but investigational use authorized. CEO retiring 2026. Trading at single-digit P/E multiple despite near-term FDA approval catalyst & growth optionality.
Read full article (2 min)